Pregnancy, Pre-eclampsia, Anti-oxidants and Endothelial Cell Function

妊娠、先兆子痫、抗氧化剂和内皮细胞功能

基本信息

  • 批准号:
    7266999
  • 负责人:
  • 金额:
    $ 33.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A current hypothesis for the etiology of pre-eclampsia is that endothelial dysfunction is secondary to oxidative stress and some clinical studies have indicated that prophylactic administration of anti-oxidants may be useful in its prevention. A much larger trial utilizing the anti-oxidants vitamin C and vitamin E is, at present, being carried out by the Maternal-Fetal Network of the NICHD to assess their effectiveness in the prevention of pre-eclampsia. Endothelial cell activation is usually a constant accompaniment with this condition. Endothelial cell activation leads to endothelial cell dysfunction and is also accompanied by expression of adhesion molecules, i.e. vascular cell adhesion molecule-1 (VCAM-1), and other adhesion molecules. This leads to adhesion of monocytes to endothelial cells resembling early atherogenesis. There is evidence in the literature that tumor necrosis factor a (TNFa) may be released by the placenta and activated leukocytes leading to activation of endothelial cells. The current proposal will mainly focus on mechanisms by which estrogens and anti-oxidants prevent TNFa-induced endothelial cell activation and apoptosis. We will, therefore, test the following four hypotheses. Hypothesis 1: Exposure of endothelial cells to TNFa leads, initially, to activation of the cells leading to VCAM-1 expression and increased synthesis of anti-apoptotic proteins, followed by stimulation of the survival pathway. Hypothesis 2: Estrogen and its metabolites prevent TNFa-induced activation, as well as apoptosis of HUVEC, by increasing the expression of eNOS and phosphorylation of Akt and ERK 1/2, in spite of the absence of migration of NFkB to the nucleus, thereby, directing the cells to the "survival pathway". Hypothesis 3: Anti-oxidants prevent endothelial cell activation and inhibit NFkB migration to the nucleus following exposure of endothelial cells to TNFa by an NO-independent Fak-mediated mechanism. Hypothesis 4: Anti-oxidants attenuate apoptosis in endothelial cells exposed to TNFa by upregulation of ERK 1/2 phosphorylation and downregulation of p38 phosphorylation. Results from these studies will also help explain the different mechanism(s) by which estrogens and anti-oxidants prevent activation of endothelial cells and apoptosis and, thereby, lay the scientific foundation by which anti-oxidants administered to women may prevent pre- eclampsia in women at risk of developing this condition. Pre-eclampsia is a condition that suddenly develops during pregnancy and is accompanied by high blood pressure, swelling of the body, and leakage of proteins. This condition can adversely affect both the mother and the fetus. Pre-eclampsia is more prevalent in Afro-Americans and is also seen in the lower socio-economic groups. Results from our studies will indicate to us which anti-oxidants are likely to be more effective than others and which can be used clinically to prevent this condition.
描述(由申请人提供):目前关于先兆子痫病因的假设是内皮功能障碍继发于氧化应激,一些临床研究表明预防性给予抗氧化剂可能有助于预防。目前,NICHD的母胎网络正在进行一项利用抗氧化剂维生素C和维生素E的更大规模的试验,以评估它们在预防先兆子痫方面的有效性。内皮细胞活化通常是这种情况的持续伴随。内皮细胞活化导致内皮细胞功能障碍,并且还伴随着粘附分子即血管细胞粘附分子-1(VCAM-1)和其它粘附分子的表达。这导致单核细胞粘附到内皮细胞,类似于早期动脉粥样硬化形成。文献中有证据表明,胎盘和活化的白细胞可释放肿瘤坏死因子a(TNF a),导致内皮细胞活化。目前的建议将主要集中在雌激素和抗氧化剂防止TNF α诱导的内皮细胞活化和凋亡的机制。因此,我们将检验以下四个假设。假设1:内皮细胞暴露于TNF α最初导致细胞活化,导致VCAM-1表达和抗凋亡蛋白的合成增加,随后刺激存活途径。假设二:雌激素及其代谢产物通过增加eNOS的表达以及Akt和ERK 1/2的磷酸化来防止TNF α诱导的HUVEC活化以及凋亡,尽管不存在NF κ B向细胞核的迁移,从而将细胞引导至“存活途径”。假设三:抗氧化剂通过NO非依赖性Fak介导的机制防止内皮细胞活化并抑制内皮细胞暴露于TNF α后NF κ B向细胞核的迁移。假设四:抗氧化剂通过上调ERK 1/2磷酸化和下调p38磷酸化来减弱暴露于TNF α的内皮细胞中的凋亡。来自这些研究的结果还将有助于解释雌激素和抗氧化剂防止内皮细胞活化和细胞凋亡的不同机制,从而奠定了向女性施用抗氧化剂可以预防处于发展这种状况的风险中的女性的先兆子痫的科学基础。先兆子痫是一种在怀孕期间突然发展的疾病,并伴有高血压,身体肿胀和蛋白质泄漏。这种情况会对母亲和胎儿产生不利影响。先兆子痫在非裔美国人中更为普遍,也见于社会经济地位较低的群体。我们的研究结果将告诉我们哪些抗氧化剂可能比其他抗氧化剂更有效,哪些抗氧化剂可以在临床上用于预防这种情况。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GAUTAM CHAUDHURI其他文献

GAUTAM CHAUDHURI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GAUTAM CHAUDHURI', 18)}}的其他基金

Gamma-Aminobutyric Acid is Synthesized by Endothelial Cells: Implications in Preeclampsia
γ-氨基丁酸由内皮细胞合成:对先兆子痫的影响
  • 批准号:
    9381915
  • 财政年份:
    2017
  • 资助金额:
    $ 33.75万
  • 项目类别:
Manipulation of macrophage Alu RNA metabolism by breast cancer cells
乳腺癌细胞对巨噬细胞 Alu RNA 代谢的调控
  • 批准号:
    8621264
  • 财政年份:
    2014
  • 资助金额:
    $ 33.75万
  • 项目类别:
SRP RNA level as a determinant of leishmanial parasitism of macrophages
SRP RNA 水平作为利什曼原虫巨噬细胞寄生的决定因素
  • 批准号:
    7628080
  • 财政年份:
    2008
  • 资助金额:
    $ 33.75万
  • 项目类别:
SRP RNA level as a determinant of leishmanial parasitism of macrophages
SRP RNA 水平作为利什曼原虫巨噬细胞寄生的决定因素
  • 批准号:
    7532609
  • 财政年份:
    2008
  • 资助金额:
    $ 33.75万
  • 项目类别:
Pregnancy, Pre-eclampsia, Anti-oxidants and Endothelial Cell Function
妊娠、先兆子痫、抗氧化剂和内皮细胞功能
  • 批准号:
    7480320
  • 财政年份:
    2006
  • 资助金额:
    $ 33.75万
  • 项目类别:
Pregnancy, Pre-eclampsia, Anti-oxidants Endothelial Cell
怀孕、先兆子痫、抗氧化剂内皮细胞
  • 批准号:
    7150738
  • 财政年份:
    2006
  • 资助金额:
    $ 33.75万
  • 项目类别:
Pregnancy, Pre-eclampsia, Anti-oxidants and Endothelial Cell Function
妊娠、先兆子痫、抗氧化剂和内皮细胞功能
  • 批准号:
    7667276
  • 财政年份:
    2006
  • 资助金额:
    $ 33.75万
  • 项目类别:
Pregnancy, Pre-eclampsia, Anti-oxidants and Endothelial Cell Function
妊娠、先兆子痫、抗氧化剂和内皮细胞功能
  • 批准号:
    7896757
  • 财政年份:
    2006
  • 资助金额:
    $ 33.75万
  • 项目类别:
Pregnancy, Pre-eclampsia, Anti-oxidants and Endothelial Cell Function
妊娠、先兆子痫、抗氧化剂和内皮细胞功能
  • 批准号:
    7683366
  • 财政年份:
    2006
  • 资助金额:
    $ 33.75万
  • 项目类别:
BUILDING INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S H
在女性健康领域建立跨学科研究生涯
  • 批准号:
    6526926
  • 财政年份:
    2000
  • 资助金额:
    $ 33.75万
  • 项目类别:

相似国自然基金

肺癌CPSF3通过调控BCLAF1 pre-mRNA APA抑制NK细胞免疫监视的作
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
α-Klotho通过SIRT7去乙酰化U3-55k调控pre-rRNA的加工在衰老BMSCs成骨分化中的作用研究
  • 批准号:
    JCZRQN202501242
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
口腔疾病综合防治和关键技术研究-基于牙周多组学多模态的 伴Pre-DM牙周炎预警模型构建
  • 批准号:
    2025C02103
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
皮肤黑素瘤中 circROR1调控FOXO4 pre-mRNA可变 剪切促进肿瘤转移的机制研究
  • 批准号:
    2024JJ5541
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
靶向SUV39H2 pre-mRNA 外显子跳跃逆转乳腺癌CDK4/6抑制剂耐 药的作用与机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
HCMV 诱导动脉粥样硬化新机制:m6A 修饰诱导 FDXR pre-mRNA 可变剪切激活血管平滑肌增殖
  • 批准号:
    2024JJ5356
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
YTHDC1通过剪接因子ROD1调控pre-ORC5剪接产物生成影响胃癌恶性进展的机制研究
  • 批准号:
    82303423
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
EBNA1调控pre-mRNA异常可变剪切促进鼻咽癌恶性进展的作用与机制研究
  • 批准号:
    2023JJ40413
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于PRE效应能量转移可见光催化烯烃双官能化研究及应用
  • 批准号:
    22378432
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Examining Pre-Pregnancy Health and Maternal Outcomes among Women Veterans
检查女性退伍军人的孕前健康和产妇结局
  • 批准号:
    10478948
  • 财政年份:
    2021
  • 资助金额:
    $ 33.75万
  • 项目类别:
Nonpersistent chemical exposure, placental development, and maternal pre- and post-pregnancy cardiovascular health
非持续性化学品接触、胎盘发育和孕产妇孕前和孕后心血管健康
  • 批准号:
    10533382
  • 财政年份:
    2021
  • 资助金额:
    $ 33.75万
  • 项目类别:
Examining Pre-Pregnancy Health and Maternal Outcomes among Women Veterans
检查女性退伍军人的孕前健康和产妇结局
  • 批准号:
    10314239
  • 财政年份:
    2021
  • 资助金额:
    $ 33.75万
  • 项目类别:
Nonpersistent chemical exposure, placental development, and maternal pre- and post-pregnancy cardiovascular health
非持续性化学品接触、胎盘发育和孕产妇孕前和孕后心血管健康
  • 批准号:
    9917782
  • 财政年份:
    2019
  • 资助金额:
    $ 33.75万
  • 项目类别:
CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs.Expectant management in pre-eclampsia?
CRADLE-4:先兆子痫的计划分娩与期待治疗能否减少不良妊娠结局?
  • 批准号:
    MR/R021376/1
  • 财政年份:
    2018
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Research Grant
PREPARE: A randomized trial of a pre-pregnancy weight loss intervention
准备:孕前减肥干预的随机试验
  • 批准号:
    8695004
  • 财政年份:
    2014
  • 资助金额:
    $ 33.75万
  • 项目类别:
PREPARE: A randomized trial of a pre-pregnancy weight loss intervention
准备:孕前减肥干预的随机试验
  • 批准号:
    9339405
  • 财政年份:
    2014
  • 资助金额:
    $ 33.75万
  • 项目类别:
Cardiac and vasculoendothelial assessment following a pre-eclamptic pregnancy.
先兆子痫妊娠后的心脏和血管内皮评估。
  • 批准号:
    279696
  • 财政年份:
    2013
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Operating Grants
Early pregnancy screening for pre-eclampsia: a proteomic based model for identifying high-risk patients.
先兆子痫的早期妊娠筛查:用于识别高危患者的基于蛋白质组学的模型。
  • 批准号:
    nhmrc : 1039119
  • 财政年份:
    2012
  • 资助金额:
    $ 33.75万
  • 项目类别:
    Postgraduate Scholarships
Understanding immune tolerance in pregnancy to discover a new intervention for the treatment of pre-eclampsia
了解妊娠期免疫耐受以发现治疗先兆子痫的新干预措施
  • 批准号:
    nhmrc : 512168
  • 财政年份:
    2008
  • 资助金额:
    $ 33.75万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了